Evidence suggests that OS is a common signature in neurodegenerative diseases such as Alzheimers disease (AD) [47,48,49], Huntingtons disease (HD) [50,51,52], Parkinsons disease (PD) [53,54,55] and, in particular, it is part of the tightly connected and multi-factorial set of mechanisms involved in the pathogenesis and progression of Amyotrophic lateral sclerosis (ALS) [25, 56,57,58]
Glutathione bypasses the bodys laborious and usually inefficient digestive process when given intravenously
Therefore, sample pretreatment (5% SSA treatment) should be performed quickly
It can lower the risk of chronic diseases
Decline in adrenal function is slow and steady and sometimes this is written off as the effect of aging